nach oben

Erschienen in:

01.08.2013 | main topic

Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges 

verfasst von: Claudio Guarneri, MD, Valentina Bevelacqua, MD, PhD, Kristina Semkova, MD, PhD, Georgi Tchernev, MD, PhD, Sven Tempel, Dipl.-Med, Uwe Wollina, MD

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 15-16/2013

Einloggen, um Zugang zu erhalten

Summary

Acral lentiginous melanoma (ALM) is an uncommon melanoma type among Caucasions. ALM bears an unfavorable prognosis because of late presentation or common misdiagnosis. Amelanotic variants, albeit rare, may pose an additional clinical challenge and may further delay the diagnosis and treatment. Thus, the threshold for biopsying even marginally suspicious lesions should be low. We present two cases of Caucasian patients with amelanotic subungual ALM, stage 2a and 2c respectively, successfully treated with a functional amputation.

Vorheriger Artikel Merkelzellkarzinom: eine Überprüfung und Aktualisierung über die Pathogenese, Diagnose und Therapieansätze

Nächster Artikel Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients

Ridgeway C, Hieken T, Ronan S, et al. Acral lentiginous melanoma. Arch Surg. 1995;130:88–92.PubMedCrossRef

Finlay RK III, Driscoll DL, Blumenson LE, Karakousis CP. Subungual melanoma: an eighteen-year review. Surgery. 1994;116:96–100.

Wouters LT, Thissen MR. The acrolentiginous melanoma: how to recognize and when to refer?. Ned Tijdschr Geneeskd. 2012;156(34):A4927.PubMed

Koch SE, Lange JR. Amelanotic melanoma: the great masquerader. J Am Acad Dermatol. 2000;45:731–4.CrossRef

Banfield CC, Redburn JC, Dawber RPR. The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol. 1998;139:276–9.PubMedCrossRef

Kato T, Suetake T, Sugiyama Y, Tabata N, Tagami H. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol. 1996;134:383–7.PubMedCrossRef

Sureda N, Phan A, Poulalhon N, Balme B, Dalle S, Thomas L. Conservative surgical management of subungual (matrix derived) melanoma: report of seven cases and literature review. Br J Dermatol. 2011;165:852–8.PubMedCrossRef

Haneke E. Ungual melanoma—controversies in diagnosis and treatment. Dermatol Ther. 2012;25:510–24.PubMedCrossRef

Rex J, Paradelo C, Mangas C, Hilari JM, Fernandez-Figueras MT, Ferrandiz C. Management of primary cutaneous malignant melanoma of the hands and feet: a clinicoprognostic study. Dermatol Surg. 2009;35:1505–13.PubMedCrossRef

Titel: Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges 
verfasst von: Claudio Guarneri, MD
Valentina Bevelacqua, MD, PhD
Kristina Semkova, MD, PhD
Georgi Tchernev, MD, PhD
Sven Tempel, Dipl.-Med
Uwe Wollina, MD
Publikationsdatum: 01.08.2013
Verlag: Springer Vienna
Erschienen in: Wiener Medizinische Wochenschrift / Ausgabe 15-16/2013
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI: https://doi.org/10.1007/s10354-013-0194-4

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 15-16/2013

Atypical fibroxanthoma—a diagnosis of exclusion!

Cutaneous side effects of vemurafenib: a case report and discussion

Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients

Merkelzellkarzinom: eine Überprüfung und Aktualisierung über die Pathogenese, Diagnose und Therapieansätze

Nachruf Prof. Dr. Walter H. Hörl 11.7.1945 – 25.6.2013

Advanced basal cell carcinoma